These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10930855)

  • 21. Antiphospholipid Syndrome with Antiβ2glicoprotein-1 Antibodies as the Cause of Recurrent Tibial Vein Thrombosis in SAPHO syndrome.
    Przepiera-Będzak H; Brzosko M
    Acta Dermatovenerol Croat; 2016 Dec; 24(4):305-306. PubMed ID: 28128085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factor V Leiden mutation in postthrombotic and non-postthrombotic venous ulcers.
    Hafner J; Kühne A; Schär B; Bombeli T; Hauser M; Lüthi R; Hänseler E
    Arch Dermatol; 2001 May; 137(5):599-603. PubMed ID: 11346337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factor V Leiden, antiphospholipid antibodies and thrombosis in systemic lupus erythematosus.
    Fijnheer R; Horbach DA; Donders RC; Vilé H; von Oort E; Nieuwenhuis HK; Gmelig-Meijling FH; de Groot PG; Derksen RH
    Thromb Haemost; 1996 Oct; 76(4):514-7. PubMed ID: 8902988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for clinical manifestations in carriers of Factor V Leiden and prothrombin gene mutations.
    DeSancho MT; Berlus N; Christos PJ; Rand J
    Blood Coagul Fibrinolysis; 2010 Jan; 21(1):11-5. PubMed ID: 19474699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Portal cavernoma in a patient with Crohn's disease associated with factor V Leiden mutation and antiphospholipid syndrome.
    Georgescu E; Dumitrescu D; Ionescu R
    J Gastrointestin Liver Dis; 2010 Dec; 19(4):449-52. PubMed ID: 21188340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Necrotic leg ulcers induced by vitamin K antagonists: five cases].
    Bezier M; Perceau G; Reguiai Z; Remy-Leroux V; Tchen T; Durlach A; Grange F; Nguyen P; Bernard P
    Ann Dermatol Venereol; 2011 Oct; 138(10):657-63. PubMed ID: 21978501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What's new: Management of venous leg ulcers: Approach to venous leg ulcers.
    Alavi A; Sibbald RG; Phillips TJ; Miller OF; Margolis DJ; Marston W; Woo K; Romanelli M; Kirsner RS
    J Am Acad Dermatol; 2016 Apr; 74(4):627-40; quiz 641-2. PubMed ID: 26979354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of acquired resistance to activated protein C associated with antiphospholipid antibodies using a novel clotting assay.
    Gardiner C; Cohen H; Jenkins A; Machin SJ; Mackie IJ
    Blood Coagul Fibrinolysis; 2006 Sep; 17(6):477-83. PubMed ID: 16905952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The terminal complement complex is generated in chronic leg ulcers in the absence of protectin (CD59).
    Balslev E; Thomsen HK; Danielsen L; Sheller J; Garred P
    APMIS; 1999 Nov; 107(11):997-1004. PubMed ID: 10598871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Higher prevalence of thrombophilia in patients with varicose veins and venous ulcers than controls.
    Darvall KA; Sam RC; Adam DJ; Silverman SH; Fegan CD; Bradbury AW
    J Vasc Surg; 2009 May; 49(5):1235-41. PubMed ID: 19307088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodies.
    Chopra N; Koren S; Greer WL; Fortin PR; Rauch J; Fortin I; Senécal JL; Docherty P; Hanly JG
    J Rheumatol; 2002 Aug; 29(8):1683-8. PubMed ID: 12180730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leg ulcers and anticardiolipin antibodies.
    Skare TL
    An Bras Dermatol; 2011; 86(3):596-7. PubMed ID: 21738987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombophilia in venous leg ulcers: a comparative study in early and later onset.
    Calistru AM; Baudrier T; Gonçalves L; Azevedo F
    Indian J Dermatol Venereol Leprol; 2012; 78(3):406. PubMed ID: 22565455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary upper-extremity deep vein thrombosis: high prevalence of thrombophilic defects.
    Hendler MF; Meschengieser SS; Blanco AN; Alberto MF; Salviú MJ; Gennari L; Lazzari MA
    Am J Hematol; 2004 Aug; 76(4):330-7. PubMed ID: 15282664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lupus anticoagulant and venous leg ulceration.
    Fink AM; Kottas-Heldenberg A; Mayer W; Partsch H; Bayer PM; Bednar R; Steiner A
    Br J Dermatol; 2002 Feb; 146(2):308-10. PubMed ID: 11903245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can inherited thrombophilia modulate the clinical phenotype of patients with antiphospholipid syndrome?
    Berman H; Ugarte-Gil MF; Espinosa G; Tàssies D; Monteagudo J; Reverter JC; Cervera R
    Clin Exp Rheumatol; 2013; 31(6):926-32. PubMed ID: 24093662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Heart failure and stasis ulcer: A significant association (prospective study of 100 cases)].
    Augey F; Pinet A; Renaudier P
    Ann Dermatol Venereol; 2010 May; 137(5):353-8. PubMed ID: 20470915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activated protein C resistance assay detects thrombotic risk factors other than factor V Leiden.
    Graf LL; Welsh CH; Qamar Z; Marlar RA
    Am J Clin Pathol; 2003 Jan; 119(1):52-60. PubMed ID: 12520697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Anti-endothelial cell antibodies in chronic leg ulcer: prevalence and significance].
    Guillet G; Garcia C; Sassolas B; Lonceint J; Youinou P
    Ann Dermatol Venereol; 2001 Dec; 128(12):1301-4. PubMed ID: 11908131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Activated protein C resistance and venous thrombophilia: molecular genetic prevalence study in the German population].
    Ehrenforth S; Klinke S; von Depka Prondzinski M; Kreuz W; Ganser A; Scharrer I
    Dtsch Med Wochenschr; 1999 Jun; 124(25-26):783-7. PubMed ID: 10414227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.